Grocery Store Stocks Q4 Winners Including Albertsons (ACI)

Albertsons Companies (NYSE:ACI) operates more than 20 grocery banners across 34 states, selling groceries, pharmacy services and own-brand products under names like Safeway, Jewel-Osco and Vons. The stock is drawing fresh attention after a rough stretch following its most recent quarterly report, with shares bouncing modestly but still sitting near the low end of their 52-week range.

At a Glance

• ACI trades at 14.16 USD, up 1.83% on the session as of June 21, 2026
• 52-week range: 13.31 to 18.22, putting the current price near multi-month lows
• Market cap: 6.81 billion USD
• Dividend yield: 4.8%
• RSI: 36.7, approaching oversold territory

A Tough Quarter in a Tough Business

Grocery retail is structurally difficult. Margins are thin, products are perishable, logistics costs are relentless, and competitors from wholesale clubs to online platforms are always pressing. Albertsons navigated that environment in its fiscal fourth quarter, posting revenues of 19.12 billion USD, a 1.9% year over year increase that landed in line with analyst expectations.

CEO Susan Morris framed the results as a win under pressure: "Fiscal 2025 was a year of disciplined execution and resilience, as we closed the year with a solid fourth quarter that delivered strong Adjusted EBITDA despite meaningful top-line pharmacy-related headwinds." The company beat EBITDA estimates, though gross margin came in exactly at consensus, nothing more.

Within the four-stock grocery group tracked this quarter, Albertsons turned in the weakest performance relative to analyst estimates and the slowest revenue growth. Kroger grew revenues 2.2% year over year, Sprouts Farmers Market posted 4.1% growth, and Grocery Outlet expanded 3.6%. That comparison mattered to the market. After earnings, ACI shares fell roughly 17%, a steeper reaction than peers absorbed.

Sector Context and Macro Noise

The broader market backdrop has not been simple either. Early 2026 brought rotation away from technology and crypto into defensive sectors, partly on fears that artificial intelligence would compress software margins and upend crypto infrastructure. By spring, geopolitical risk around the US conflict with Iran became the dominant narrative, pushing investors toward oil price sensitivity and inflation concerns rather than growth stock debates. Grocery stocks, theoretically defensive, have not been immune to the chop.

One structural advantage the sector holds: e-commerce penetration in grocery remains lower than almost any other retail category. Customers still prefer to pick their own produce and check expiration dates in person. That preference provides a partial moat, though the online threat is real and will grow over time.

What the Numbers Say

Valuation

At 14.16 USD with a market cap of 6.81 billion, ACI is trading near its 52-week low of 13.31. The stock has shed substantial ground from its 52-week high of 18.22, a decline of roughly 22% from peak. For a grocer with over 19 billion in quarterly revenue, the valuation looks compressed, though thin-margin businesses in this sector rarely command rich multiples.

Momentum

The RSI of 36.7 signals weak near-term momentum. A reading below 30 is conventionally considered oversold; ACI is not far from that threshold. The 1.83% single-day gain on June 21 suggests some stabilization, but the broader trend off the post-earnings drop has not reversed decisively.

Yield

The 4.8% dividend yield is meaningful for an income-focused investor. At current prices, that yield is elevated partly because the share price has fallen, so it reflects both the payout and the market's skepticism about near-term growth. Whether the dividend is sustainable depends on free cash flow generation the company has not yet detailed for the coming fiscal year.

Bull Case vs. Bear Case Risks

The bull argument rests on a few pillars. ACI's portfolio of recognizable regional banners gives it geographic diversity that a single-brand grocer lacks. The EBITDA beat suggests operational discipline even when the top line faces pharmacy headwinds. A near-oversold RSI and a nearly 4.8% yield could attract value and income investors willing to wait out the volatility.

The bear case is harder to dismiss. Pharmacy revenue weakness is not a one-quarter story; reimbursement pressure and competition from standalone pharmacy chains and retail giants have been grinding at grocery pharmacy economics for years. Albertsons grew revenue more slowly than all three peers this quarter, and that peer comparison is likely to stay on investors' minds. The stock is still well above its 52-week floor of 13.31, meaning a further leg down is not out of the question if the next quarterly print disappoints.

Frequently Asked Questions

What banners does Albertsons operate?

Albertsons runs more than 20 grocery banners across 34 states, including Safeway, Jewel-Osco and Vons, among others. The stores offer groceries, pharmacy services and own-brand products.

Why has ACI stock dropped so much recently?

Shares fell roughly 17% after the company reported fiscal fourth-quarter results that, while meeting revenue estimates, showed the slowest growth among the four major grocery stocks tracked this period. Pharmacy-related revenue headwinds were a specific concern cited by management.

Is the Albertsons dividend safe?

The company currently yields 4.8% at the June 21 price of 14.16. Dividend safety depends on ongoing free cash flow, which investors will evaluate more closely as the company reports future quarters amid pharmacy margin pressure.

How does Albertsons compare to Kroger and Sprouts?

In the most recent fiscal quarter, Albertsons posted 1.9% revenue growth versus Kroger at 2.2% and Sprouts at 4.1%. Kroger is also a much larger operator at roughly 46 billion in quarterly revenue, while Sprouts focuses on natural and organic products in a faster-growing niche.

Where ACI Stands Heading Into the Second Half of 2026

Albertsons is a large, established grocer trading near its lowest levels in a year, paying a substantial dividend and generating real revenue, just not growing it as fast as investors had hoped. The pharmacy headwinds are known and will take time to resolve. For now, the stock sits at a crossroads between a potential value opportunity and a fundamentals story that still needs to improve.